BioServe to Provide Genetic Testing for NGC Medical | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioServe said today that it will provide its genetic testing services for NGC Medical's nutrigenomics testing business.

Under the agreement, BioServe will provide Italy's NGC Medical with its CLIA-certified genomics services, including DNA extraction, QC DNA, and control DNA for the NutriGeneCode testing service.

Beltsville, Md.-based BioServe said that it expects to process around 10,000 NutriGeneCode tests in the next year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.